炎症性皮肤疾病中的药物微生物组学:过去,现在和未来
Juna Khang1,2, Rebeca Martinez1, Katherine Brag3,2
1Department of Dermatology, Brigham and Women's Hospital, Boston, MA, United States.
Frontiers in microbiology
|January 30, 2026
概括
药理学微生物组研究探讨了肠道微生物如何影响药物反应,为炎症性皮肤疾病提供个性化药物. 肠道微生物组可以预测治疗成功,指导未来的治疗选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 药理学微生物组研究研究了肠道微生物组对药物的药理动力学和药理动力学的影响.
- 针对慢性炎症疾病的个性化医疗,特别是皮肤病学,面临着挑战,因为患者对治疗的反应不可预测.
- 目前炎症性皮肤疾病的治疗决策通常依赖于医生的偏好,而不是预测的个体反应,导致不理想的结果.
研究的目的:
- 审查肠道微生物群作为炎症性皮肤疾病治疗反应的预测生物标志物的作用.
- 综合来自瘤学,炎症性肠病和类风湿性关节炎的证据,关于药物微生物组学.
- 探索基于微生物组的诊断在皮肤病学中指导治疗选择的潜力.
主要方法:
- 文献评论综合了关于药物微生物组学的证据.
- 检查肠道微生物特征,预测瘤治疗反应 (黑色素瘤免疫疗法).
- 从炎症性肠道疾病和类风湿性关节炎,以及皮肤病的肠道失生症 (牛皮,性炎) 的转化模型的分析.
主要成果:
- 肠道微生物特征已经显示出在黑色素瘤中免疫治疗反应的预测价值.
- 肠道失调症和皮肤病症,如牛皮和状腺炎之间存在已确定的联系.
- 来自IBD和RA的转化模型突出显示了微生物组对炎症疾病进展和治疗的影响.
结论:
- 肠道微生物组作为炎症性皮肤疾病治疗反应的预测生物标志物具有显著的潜力.
- 基于微生物组的诊断可以通过指导治疗选择来彻底改变皮肤病学领域的个性化医学.
- 需要进一步的研究来将这些发现转化为临床实践,以改善患者的治疗结果.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
01:23Skin Diseases and Disorders
5.4K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.4K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
980
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
980
01:21Inflammatory Bowel Disease V: Surgical Management
516
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
516
01:29Inflammatory Bowel Disease IV: Pharmacological Management
604
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
604
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
735
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
735